Logo

Genospectra Licenses Affymetrix Bead Technology for RNA Quantification

Nov 11, 2004

NEW YORK, Nov. 11 (GenomeWeb News) - Genospectra has taken a non-exclusive license to Affymetrix patents related to bead technology and gene-expression analysis, the two companies said yesterday afternoon.


Genospectra will use the technology with its signal-amplification techniques to develop methods to quantify RNA directly from cell lysates or tissue homogenates.

 

Financial details were not disclosed.

 

In April, Affymetrix said it would begin offering "reasonable terms" and would license or sell in "selected areas" some of its most recently issued patents, as well as some early patents relating to bead-based molecular technologies.

Breaking News
The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.